Literature DB >> 20410278

Integrin alpha4beta7 is downregulated on the surfaces of simian immunodeficiency virus SIVmac239-infected cells.

Melisa L Budde1, Jennifer J Lhost, Dawn M Dudley, Eva G Rakasz, David H O'Connor.   

Abstract

Simian immunodeficiency virus (SIV) and human immunodeficiency virus (HIV) infection results in an early and enduring depletion of intestinal CD4(+) T cells. SIV and HIV bind integrin alpha4beta7, thereby facilitating infection of lymphocytes that home to the gut-associated lymphoid tissue (GALT). Using an ex vivo flow cytometry assay, we found that SIVmac239-infected cells expressed significantly lower levels of integrin alpha4beta7 than did uninfected cells. This finding suggested a potential viral effect on integrin alpha4beta7 expression. Using an in vitro model, we confirmed that integrin alpha4beta7 was downregulated on the surfaces of SIVmac239-infected cells. Further, modulation of integrin alpha4beta7 was dependent on de novo synthesis of viral proteins, but neither cell death, the release of a soluble factor, nor a change in activation state was involved. Downregulation of integrin alpha4beta7 may have an unappreciated role in the CD4 depletion of the mucosal-associated lymphoid compartments, susceptibility to superinfection, and/or immune evasion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20410278      PMCID: PMC2903238          DOI: 10.1128/JVI.00430-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry.

Authors:  A Takada; S Watanabe; H Ito; K Okazaki; H Kida; Y Kawaoka
Journal:  Virology       Date:  2000-12-05       Impact factor: 3.616

2.  Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells.

Authors:  Qingsheng Li; Lijie Duan; Jacob D Estes; Zhong-Min Ma; Tracy Rourke; Yichuan Wang; Cavan Reilly; John Carlis; Christopher J Miller; Ashley T Haase
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

3.  Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins.

Authors:  J L Rossio; M T Esser; K Suryanarayana; D K Schneider; J W Bess; G M Vasquez; T A Wiltrout; E Chertova; M K Grimes; Q Sattentau; L O Arthur; L E Henderson; J D Lifson
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

4.  Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection.

Authors:  Joseph J Mattapallil; Daniel C Douek; Brenna Hill; Yoshiaki Nishimura; Malcolm Martin; Mario Roederer
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

5.  SIVsmmPBj14 induces expression of a mucosal integrin on macaque lymphocytes.

Authors:  S Gummuluru; F J Novembre; B Seshi; S Dewhurst
Journal:  Virology       Date:  1996-01-01       Impact factor: 3.616

6.  Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection.

Authors:  R S Veazey; M DeMaria; L V Chalifoux; D E Shvetz; D R Pauley; H L Knight; M Rosenzweig; R P Johnson; R C Desrosiers; A A Lackner
Journal:  Science       Date:  1998-04-17       Impact factor: 47.728

7.  The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4.

Authors:  Nico Michel; Ina Allespach; Stephanie Venzke; Oliver T Fackler; Oliver T Keppler
Journal:  Curr Biol       Date:  2005-04-26       Impact factor: 10.834

8.  Characterization of the cutaneous exanthem in macaques infected with a Nef gene variant of SIVmac239.

Authors:  V G Sasseville; J B Rottman; Z Du; R Veazey; H L Knight; D Caunt; R C Desrosiers; A A Lackner
Journal:  J Invest Dermatol       Date:  1998-06       Impact factor: 8.551

Review 9.  The beta 7 integrins in mucosal homing and retention.

Authors:  S K Shaw; M B Brenner
Journal:  Semin Immunol       Date:  1995-10       Impact factor: 11.130

10.  Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine.

Authors:  L O Arthur; J W Bess; E N Chertova; J L Rossio; M T Esser; R E Benveniste; L E Henderson; J D Lifson
Journal:  AIDS Res Hum Retroviruses       Date:  1998-10       Impact factor: 2.205

View more
  5 in total

1.  Equine herpesvirus type 4 UL56 and UL49.5 proteins downregulate cell surface major histocompatibility complex class I expression independently of each other.

Authors:  Abdelrahman Said; Walid Azab; Armando Damiani; Nikolaus Osterrieder
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

2.  A genetic polymorphism of FREM1 is associated with resistance against HIV infection in the Pumwani sex worker cohort.

Authors:  Ma Luo; James Sainsbury; Jeffrey Tuff; Philip A Lacap; Xin-Yong Yuan; Taha Hirbod; Joshua Kimani; Charles Wachihi; Sue Ramdahin; Thomas Bielawny; Joanne Embree; Kristina Broliden; T Blake Ball; Francis A Plummer
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

3.  Treatment-Naïve HIV-Infected Patients Have Fewer Gut-Homing β7 Memory CD4 T Cells than Healthy Controls.

Authors:  Nada Fadul; Jacob Couturier; Xiaoying Yu; Claudia Kozinetz; Roberto Arduino; Dorothy E Lewis
Journal:  South Med J       Date:  2017-11       Impact factor: 0.954

4.  Polymorphisms in the α4 integrin of neotropical primates: insights for binding of natural ligands and HIV-1 gp120 to the human α4β7.

Authors:  Mirela Darc; Sabrina H Hait; Esmeralda A Soares; Claudia Cicala; Hector N Seuanez; Elizabeth S Machado; James A Arthos; Marcelo A Soares
Journal:  PLoS One       Date:  2011-09-02       Impact factor: 3.240

5.  Frequency of Effector Memory Cells Expressing Integrin α4β7 Is Associated With TGF-β1 Levels in Therapy Naïve HIV Infected Women With Low CD4+ T Cell Count.

Authors:  Nandini J Kasarpalkar; Shilpa Bhowmick; Vainav Patel; Lalita Savardekar; Sachee Agrawal; Jayanthi Shastri; Vikrant M Bhor
Journal:  Front Immunol       Date:  2021-03-22       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.